Lawrence Steinman - 21 Jun 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role: Director
Signature: /s/ Larry Steinman
Issuer symbol: KTTA
Transactions as of: 21 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 22 Jun 2022, 16:30:46 UTC
Previous filing: 17 Jun 2022
Next filing: 23 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KTTA	Common Stock	Award	$0	+652,174	+109%	$0.000000	1,252,174	21 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KTTA	Stock option (to acquire common stock)	Award	$0	+100,000		$0.000000	100,000	02 Aug 2021	Common Stock	600,000	$6.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock of the Issuer issued in connection with the acquisition of the ALPHA-5 Integrin, LLC on June 21, 2022.
F2	The Reporting Person was granted 100,000 stock options. The stock options have a ten-year term and vest over two years, subject to reporting person remaining employed and in good standing, one-half vesting on the first anniversary of the grant date, and the remainder vesting on the second anniversary of the grant date.